Lumos Pharma Inc. buy melinda
Start price
13.10.17
/
50%
€95.14
Target price
27.12.17
€129.89
Performance (%)
-30.46%
End price
27.12.17
€66.16
Summary
This prediction ended on 27.12.17 with a price of €66.16. Massive losses of -30.46% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Lumos Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % | 62,27 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % | 85,45 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % | 76,58 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % | 68,71 % |
Comments by melinda for this prediction
In the thread NewLink Genetics Corp diskutieren
(Vom Mitglied beendet)
Stopped prediction by melinda for Lumos Pharma Inc.
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€105.48
13.10.17
13.10.17
€144.00
27.12.17
27.12.17
-30.46%
27.12.17
27.12.17
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€147.67
10.09.17
10.09.17
€194.83
11.09.17
11.09.17
-10.78%
11.09.17
11.09.17
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€52.12
14.06.17
14.06.17
€121.77
08.09.17
08.09.17
151.87%
08.09.17
08.09.17